{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:42:58Z","timestamp":1774878178711,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A common approach for sequencing studies is to do joint-calling and store variants of all samples in a single file. If new samples are continually added or controls are re-used for several studies, the cost and time required to perform joint-calling for each analysis can become prohibitive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We present ATAV, an analysis platform for large-scale whole-exome and whole-genome sequencing projects. ATAV stores variant and per site coverage data for all samples in a centralized database, which is efficiently queried by ATAV to support diagnostic analyses for trios and singletons, as well as rare-variant collapsing analyses for finding disease associations in complex diseases. Runtime logs ensure full reproducibility and the modularized ATAV framework makes it extensible to continuous development. Besides helping with the identification of disease-causing variants for a range of diseases, ATAV has also enabled the discovery of disease-genes by rare-variant collapsing on datasets containing more than 20,000 samples. Analyses to date have been performed on data of more than 110,000 individuals demonstrating the scalability of the framework.<\/jats:p>\n                    <jats:p>\n                      To allow users to easily access variant-level data directly from the database, we provide a web-based interface, the ATAV data browser (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/atavdb.org\/\">http:\/\/atavdb.org\/<\/jats:ext-link>\n                      ). Through this browser, summary-level data for more than 40,000 samples can be queried by the general public representing a mix of cases and controls of diverse ancestries. Users have access to phenotype categories of variant carriers, as well as predicted ancestry, gender, and quality metrics. In contrast to many other platforms, the data browser is able to show data of newly-added samples in real-time and therefore evolves rapidly as more and more samples are sequenced.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Through ATAV, users have public access to one of the largest variant databases for patients sequenced at a tertiary care center and can look up any genes or variants of interest. Additionally, since the entire code is freely available on GitHub, ATAV can easily be deployed by other groups that wish to build their own platform, database, and user interface.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-021-04071-1","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T14:03:58Z","timestamp":1616508238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["ATAV: a comprehensive platform for population-scale genomic analyses"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-8612","authenticated-orcid":false,"given":"Zhong","family":"Ren","sequence":"first","affiliation":[]},{"given":"Gundula","family":"Povysil","sequence":"additional","affiliation":[]},{"given":"Joseph A.","family":"Hostyk","sequence":"additional","affiliation":[]},{"given":"Hongzhu","family":"Cui","sequence":"additional","affiliation":[]},{"given":"Nitin","family":"Bhardwaj","sequence":"additional","affiliation":[]},{"given":"David B.","family":"Goldstein","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"4071_CR1","doi-asserted-by":"publisher","unstructured":"Hout CV Van, Tachmazidou I, Backman JD, Hoffman JX, Ye B, Pandey AK, et al. Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank. bioRxiv. 2019; 572347. https:\/\/doi.org\/10.1101\/572347.","DOI":"10.1101\/572347"},{"key":"4071_CR2","doi-asserted-by":"publisher","unstructured":"Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. bioRxiv. 2019; 563866. https:\/\/doi.org\/10.1101\/563866.","DOI":"10.1101\/563866"},{"key":"4071_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"key":"4071_CR4","doi-asserted-by":"publisher","first-page":"e1005492","DOI":"10.1371\/journal.pgen.1005492","volume":"11","author":"S Petrovski","year":"2015","unstructured":"Petrovski S, Gussow AB, Wang Q, Halvorsen M, Han Y, Weir WH, et al. The intolerance of regulatory sequence to genetic variation predicts gene dosage sensitivity. PLoS Genet. 2015;11:e1005492. https:\/\/doi.org\/10.1371\/journal.pgen.1005492.","journal-title":"PLoS Genet"},{"key":"4071_CR5","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/bioinformatics\/btw199","volume":"32","author":"H Gu\u00f0bjartsson","year":"2016","unstructured":"Gu\u00f0bjartsson H, Georgsson GF, Gu\u00f0j\u00f3nsson SA, Valdimarsson R\u00de, Sigur\u00f0sson JH, Stef\u00e1nsson SK, et al. GORpipe: a query tool for working with sequence data based on a Genomic Ordered Relational (GOR) architecture. Bioinformatics. 2016;32:3081\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btw199.","journal-title":"Bioinformatics"},{"key":"4071_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms. SnpEff Fly (Austin). 2012;6:80\u201392. https:\/\/doi.org\/10.4161\/fly.19695.","journal-title":"SnpEff Fly (Austin)"},{"key":"4071_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391. https:\/\/doi.org\/10.1038\/nature19057.","journal-title":"Nature"},{"key":"4071_CR8","doi-asserted-by":"publisher","first-page":"aaf6814","DOI":"10.1126\/science.aaf6814","volume":"354","author":"FE Dewey","year":"2016","unstructured":"Dewey FE, Murray MF, Overton JD, Habegger L, Leader JB, Fetterolf SN, et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science. 2016;354:aaf6814. https:\/\/doi.org\/10.1126\/science.aaf6814.","journal-title":"Science"},{"key":"4071_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41467-017-00141-2","volume":"8","author":"S Gelfman","year":"2017","unstructured":"Gelfman S, Wang Q, McSweeney KM, Ren Z, La Carpia F, Halvorsen M, et al. Annotating pathogenic non-coding variants in genic regions. Nat Commun. 2017;8:236. https:\/\/doi.org\/10.1038\/s41467-017-00141-2.","journal-title":"Nat Commun"},{"key":"4071_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/J.AJHG.2018.12.020","volume":"104","author":"TJ Hayeck","year":"2019","unstructured":"Hayeck TJ, Stong N, Wolock CJ, Copeland B, Kamalakaran S, Goldstein DB, et al. Improved pathogenic variant localization via a hierarchical model of sub-regional intolerance. Am J Hum Genet. 2019;104:299\u2013309. https:\/\/doi.org\/10.1016\/J.AJHG.2018.12.020.","journal-title":"Am J Hum Genet"},{"key":"4071_CR11","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1101\/gr.226589.117","volume":"27","author":"J Traynelis","year":"2017","unstructured":"Traynelis J, Silk M, Wang Q, Berkovic SF, Liu L, Ascher DB, et al. Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation. Genome Res. 2017;27:1715\u201329. https:\/\/doi.org\/10.1101\/gr.226589.117.","journal-title":"Genome Res"},{"key":"4071_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13059-016-0869-4","volume":"17","author":"AB Gussow","year":"2016","unstructured":"Gussow AB, Petrovski S, Wang Q, Allen AS, Goldstein DB. The intolerance to functional genetic variation of protein domains predicts the localization of pathogenic mutations within genes. Genome Biol. 2016;17:9. https:\/\/doi.org\/10.1186\/s13059-016-0869-4.","journal-title":"Genome Biol"},{"key":"4071_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/J.AJHG.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877\u201385. https:\/\/doi.org\/10.1016\/J.AJHG.2016.08.016.","journal-title":"Am J Hum Genet"},{"key":"4071_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41588-018-0167-z","volume":"50","author":"L Sundaram","year":"2018","unstructured":"Sundaram L, Gao H, Padigepati SR, McRae JF, Li Y, Kosmicki JA, et al. Predicting the clinical impact of human mutation with deep neural networks. Nat Genet. 2018;50:1161\u201370. https:\/\/doi.org\/10.1038\/s41588-018-0167-z.","journal-title":"Nat Genet"},{"key":"4071_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41588-018-0294-6","volume":"51","author":"JM Havrilla","year":"2019","unstructured":"Havrilla JM, Pedersen BS, Layer RM, Quinlan AR. A map of constrained coding regions in the human genome. Nat Genet. 2019;51:88\u201395. https:\/\/doi.org\/10.1038\/s41588-018-0294-6.","journal-title":"Nat Genet"},{"issue":"Database issue","key":"4071_CR16","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue):D980\u20135. https:\/\/doi.org\/10.1093\/nar\/gkt1113.","journal-title":"Nucleic Acids Res"},{"key":"4071_CR17","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u20137. https:\/\/doi.org\/10.1093\/nar\/gkx1153.","journal-title":"Nucleic Acids Res"},{"key":"4071_CR18","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen: the clinical genome resource. N Engl J Med. 2015;372:2235\u201342. https:\/\/doi.org\/10.1056\/NEJMsr1406261.","journal-title":"N Engl J Med"},{"key":"4071_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NST, et al. Human gene mutation database (HGMD\u00ae): 2003 update. Hum Mutat. 2003;21:577\u201381. https:\/\/doi.org\/10.1002\/humu.10212.","journal-title":"Hum Mutat"},{"key":"4071_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"4071_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139. https:\/\/doi.org\/10.1038\/nmeth0410-248.","journal-title":"Nat Methods"},{"key":"4071_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41576-019-0177-4","volume":"20","author":"G Povysil","year":"2019","unstructured":"Povysil G, Petrovski S, Hostyk J, Aggarwal V, Allen AS, Goldstein DB. Rare-variant collapsing analyses for complex traits: guidelines and applications. Nat Rev Genet. 2019;20:747\u201359.","journal-title":"Nat Rev Genet"},{"key":"4071_CR23","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen W-M. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867\u201373. https:\/\/doi.org\/10.1093\/bioinformatics\/btq559.","journal-title":"Bioinformatics"},{"key":"4071_CR24","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1093\/bioinformatics\/btx299","volume":"33","author":"G Abraham","year":"2017","unstructured":"Abraham G, Qiu Y, Inouye M. FlashPCA2: principal component analysis of Biobank-scale genotype datasets. Bioinformatics. 2017;33:2776\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btx299.","journal-title":"Bioinformatics"},{"key":"4071_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1164\/rccm.201610-2088OC","volume":"196","author":"S Petrovski","year":"2017","unstructured":"Petrovski S, Todd JL, Durheim MT, Wang Q, Chien JW, Kelly FL, et al. An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis. Am J Respir Crit Care Med. 2017;196:82\u201393. https:\/\/doi.org\/10.1164\/rccm.201610-2088OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4071_CR26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/acn3.582","volume":"5","author":"NS Raghavan","year":"2018","unstructured":"Raghavan NS, Brickman AM, Andrews H, Manly JJ, Schupf N, Lantigua R, et al. Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2018;5:832\u201342. https:\/\/doi.org\/10.1002\/acn3.582.","journal-title":"Ann Clin Transl Neurol"},{"key":"4071_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1474-4422(16)30359-3","volume":"16","author":"AS Allen","year":"2017","unstructured":"Allen AS, Bellows ST, Berkovic SF, Bridgers J, Burgess R, Cavalleri G, et al. Ultra-rare genetic variation in common epilepsies: a case-control sequencing study. Lancet Neurol. 2017;16:135\u201343. https:\/\/doi.org\/10.1016\/S1474-4422(16)30359-3.","journal-title":"Lancet Neurol"},{"key":"4071_CR28","doi-asserted-by":"publisher","first-page":"e1007104","DOI":"10.1371\/journal.pgen.1007104","volume":"13","author":"X Zhu","year":"2017","unstructured":"Zhu X, Padmanabhan R, Copeland B, Bridgers J, Ren Z, Kamalakaran S, et al. A case-control collapsing analysis identifies epilepsy genes implicated in trio sequencing studies focused on de novo mutations. PLoS Genet. 2017;13:e1007104. https:\/\/doi.org\/10.1371\/journal.pgen.1007104.","journal-title":"PLoS Genet"},{"key":"4071_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24596","volume":"79","author":"RD Bagnall","year":"2016","unstructured":"Bagnall RD, Crompton DE, Petrovski S, Lam L, Cutmore C, Garry SI, et al. Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy. Ann Neurol. 2016;79:522\u201334. https:\/\/doi.org\/10.1002\/ana.24596.","journal-title":"Ann Neurol"},{"key":"4071_CR30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/J.AJHG.2017.09.018","volume":"101","author":"S Sanna-Cherchi","year":"2017","unstructured":"Sanna-Cherchi S, Khan K, Westland R, Krithivasan P, Fievet L, Rasouly HM, et al. Exome-wide association study identifies GREB1L mutations in congenital kidney malformations. Am J Hum Genet. 2017;101:789\u2013802. https:\/\/doi.org\/10.1016\/J.AJHG.2017.09.018.","journal-title":"Am J Hum Genet"},{"key":"4071_CR31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1681\/ASN.2018090909","volume":"30","author":"S Cameron-Christie","year":"2019","unstructured":"Cameron-Christie S, Wolock CJ, Groopman E, Petrovski S, Kamalakaran S, Povysil G, et al. Exome-based rare-variant analyses in CKD. J Am Soc Nephrol. 2019;30:1109\u201322. https:\/\/doi.org\/10.1681\/ASN.2018090909.","journal-title":"J Am Soc Nephrol"},{"key":"4071_CR32","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436\u201341. https:\/\/doi.org\/10.1126\/science.aaa3650.","journal-title":"Science"},{"key":"4071_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1101\/gr.243592.118","volume":"29","author":"S Gelfman","year":"2019","unstructured":"Gelfman S, Dugger S, de Araujo Martins-Moreno C, Ren Z, Wolock CJ, Shneider NA, et al. A new approach for rare variation collapsing on functional protein domains implicates specific genic regions in ALS. Genome Res. 2019;29:809\u201318. https:\/\/doi.org\/10.1101\/gr.243592.118.","journal-title":"Genome Res"},{"key":"4071_CR34","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/s41436-019-0495-0","volume":"21","author":"CJ Wolock","year":"2019","unstructured":"Wolock CJ, Stong N, Ma CJ, Nagasaki T, Lee W, Tsang SH, et al. A case\u2013control collapsing analysis identifies retinal dystrophy genes associated with ophthalmic disease in patients with no pathogenic ABCA4 variants. Genet Med. 2019;21:2336\u201344.","journal-title":"Genet Med"},{"key":"4071_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.6500","author":"G Povysil","year":"2020","unstructured":"Povysil G, Chazara O, Carss KJ, Deevi SVV, Wang Q, Armisen J, et al. Assessing the role of rare genetic variation in patients with heart failure. JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.6500.","journal-title":"JAMA Cardiol"},{"key":"4071_CR36","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1908753","author":"KE Stanley","year":"2020","unstructured":"Stanley KE, Giordano J, Thorsten V, Buchovecky C, Thomas A, Ganapathi M, et al. Causal Genetic Variants in Stillbirth. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/nejmoa1908753.","journal-title":"N Engl J Med"},{"key":"4071_CR37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/gim.2014.191","volume":"17","author":"X Zhu","year":"2015","unstructured":"Zhu X, Petrovski S, Xie P, Ruzzo EK, Lu Y-F, McSweeney KM, et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med. 2015;17:774. https:\/\/doi.org\/10.1038\/gim.2014.191.","journal-title":"Genet Med"},{"key":"4071_CR38","doi-asserted-by":"publisher","first-page":"a000257","DOI":"10.1101\/mcs.a000257","volume":"1","author":"S Petrovski","year":"2015","unstructured":"Petrovski S, Shashi V, Petrou S, Schoch K, McSweeney KM, Dhindsa RS, et al. Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition. Mol Case Stud. 2015;1:a000257.","journal-title":"Mol Case Stud"},{"key":"4071_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12439","volume":"501","author":"AS Allen","year":"2013","unstructured":"Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217\u201321. https:\/\/doi.org\/10.1038\/nature12439.","journal-title":"Nature"},{"key":"4071_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ajhg.2017.08.013","volume":"101","author":"CT Myers","year":"2017","unstructured":"Myers CT, Stong N, Mountier EI, Helbig KL, Freytag S, Sullivan JE, et al. De Novo mutations in PPP3CA cause severe neurodevelopmental disease with seizures. Am J Hum Genet. 2017;101:516\u201324.","journal-title":"Am J Hum Genet"},{"key":"4071_CR41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.ajhg.2016.03.011","volume":"98","author":"S Petrovski","year":"2016","unstructured":"Petrovski S, K\u00fcry S, Myers CT, Anyane-Yeboa K, Cogn\u00e9 B, Bialer M, et al. Germline de Novo mutations in GNB1 cause severe neurodevelopmental disability, hypotonia, and seizures. Am J Hum Genet. 2016;98:1001\u201310.","journal-title":"Am J Hum Genet"},{"key":"4071_CR42","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ng.2358","volume":"44","author":"EL Heinzen","year":"2012","unstructured":"Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, De Vries B, Tiziano FD, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012;44:1030\u20134.","journal-title":"Nat Genet"},{"key":"4071_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med. 2019;380:142\u201351.","journal-title":"N Engl J Med"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-021-04071-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T14:04:58Z","timestamp":1616508298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-021-04071-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1186\/s12859-021-04071-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.08.136507","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DBG is a founder of and holds equity in Praxis, holds equity in Q-State Biosciences, serves as a consultant to AstraZeneca, and has received research support from Janssen, Gilead, Biogen, AstraZeneca, and Union Chimique Belge (UCB). ZR, GP, JAH, HC, and NB declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}